The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD von Uhm, J, Hamad, N, Michelis, F V, Shanavas, M, Kuruvilla, J, Gupta, V, Lipton, J H, Messner, H A, Seftel, M, Kim, D D

Volltext

Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning von Shanavas, M, Messner, H A, Atenafu, E G, Kim, D H, Kuruvilla, J, Lipton, J H, Uhm, J, Seftel, M, Alam, N, Gupta, V

Volltext

Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT von (Dong Hwan) Kim, D, Al-Dawsari, G, Chang, H, Panzarella, T, Gupta, V, Kuruvilla, J, Lipton, J H, Messner, H A

Volltext

Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models von Kim, D, Won, H-H, Su, S, Cheng, L, Xu, W, Hamad, N, Uhm, J, Gupta, V, Kuruvilla, J, Messner, H A, Lipton, J H

Volltext

Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR von Michelis, F V, Atenafu, E G, Gupta, V, Kim, D D, Kuruvilla, J, Lambie, A, Lipton, J H, Loach, D, Messner, H A

Volltext

Long-Term Medical Outcomes and Quality-of-Life Assessment of Patients With Chronic Myeloid Leukemia Followed at Least 10 Years After Allogeneic Bone Marrow Transplantation von KISS, T. L, ABDOLELL, M, JAMAL, N, MINDEN, LIPTON, J. H, MESSNER, H. A

Volltext

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation von HASEGAWA, W, POND, G. R, RIFKIND, J. T, MESSNER, H. A, LAU, A, DALY, A. S, KISS, T. L, KOTCHETKOVA, N, GALAL, A, LIPTON, J. H

Volltext

Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation von MARRAS, T. K, CHAN, C. K, LIPTON, J. H, MESSNER, H. A, SZALAI, J. P, LAUPACIS, A

Volltext

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease von TOZE, C. L, GALAL, A, VOSS, N. J, KISS, T. L, MESSNER, H. A, LAVOIE, J. C, FORREST, D. L, SONG, K. W, SMITH, C. A, LIPTON, J, BARNETT, M. J, SHEPHERD, J. D, CONNEALLY, E. A, HOGGE, D. E, NANTEL, S. H, NEVILL, T. J, SUTHERLAND, H. J, CONNORS, J. M

Volltext

Ankyloglossia: controversies in management von Messner, Anna H, Lalakea, M.Lauren

Volltext

Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR von Kohli, R, Xu, W, Brandwein, J, Minden, M D, Schimmer, A, Schuh, A C, Lipton, J H, Yee, K, Messner, H A, Gupta, V

Volltext

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms von SUTHERLAND, H. J, FYLES, G. M, ADAMS, G, HAO, Y, LIPTON, J. H, MINDEN, M. D, MEHARCHAND, J. M, ATKINS, H, TEJPAR, I, MESSNER, H. A

Volltext

Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2 von Michelis, F V, Messner, H A, Atenafu, E G, McGillis, L, Lambie, A, Uhm, J, Alam, N, Seftel, M D, Gupta, V, Kuruvilla, J, Lipton, J H, Kim, D D

Volltext

Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument von Marras, T K, Szalai, J P, Chan, C K, Lipton, J H, Messner, H A, Laupacis, A

Volltext

Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation von Mayo, S, Messner, H A, Rourke, S B, Howell, D, Victor, J C, Kuruvilla, J, Lipton, J H, Gupta, V, Kim, D D, Piescic, C, Breen, D, Lambie, A, Loach, D, Michelis, F V, Alam, N, Uhm, J, McGillis, L, Metcalfe, K

Volltext

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission von Michelis, F V, Atenafu, E G, Gupta, V, Kim, D D, Kuruvilla, J, Lipton, J H, Loach, D, Seftel, M D, Uhm, J, Alam, N, Lambie, A, McGillis, L, Messner, H A

Volltext

Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation von Alam, N, Atenafu, E G, Kuruvilla, J, Uhm, J, Lipton, J H, Messner, H A, Kim, D H, Seftel, M, Gupta, V

Volltext

Long-term outcome of allogeneic transplants in acute myeloid leukemia von MESSNER, H. A

Volltext

Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asym... von KISS, T. L, CHANG, H, DALY, A, MESSNER, H. A, JAMAL, N, SPANER, D, RUBIN, S, LIPTON, J. H

Volltext

Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD von Alam, N, Xu, W, Atenafu, E G, Uhm, J, Seftel, M, Gupta, V, Kuruvilla, J, Lipton, J H, Messner, H A, Kim, D D H

Volltext